Inhibition of PI3K prevents the proliferation and differentiation of human lung fibroblasts into myofibroblasts: The role of class I P110 isoforms

Enrico Conte, Mary Fruciano, Evelina Fagone, Elisa Gili, Filippo Caraci, Maria Iemmolo, Nunzio Crimi, Carlo Vancheri

Research output: Contribution to journalArticle

Abstract

Idiopathic pulmonary fibrosis (IPF) is a progressive fibroproliferative disease characterized by an accumulation of fibroblasts and myofibroblasts in the alveolar wall. Even though the pathogenesis of this fatal disorder remains unclear, transforming growth factor-β (TGF-β)-induced differentiation and proliferation of myofibroblasts is recognized as a primary event. The molecular pathways involved in TGF-β signalling are generally Smad-dependent yet Smad-independent pathways, including phosphatidylinositol-3-kinase/protein kinase B (PI3K/Akt), have been recently proposed. In this research we established ex-vivo cultures of human lung fibroblasts and we investigated the role of the PI3K/Akt pathway in two critical stages of the fibrotic process induced by TGF-β: fibroblast proliferation and differentiation into myofibroblasts. Here we show that the pan-inhibitor of PI3Ks LY294002 is able to abrogate the TGF-β-induced increase in cell proliferation, in α- smooth muscle actin expression and in collagen production besides inhibiting Akt phosphorylation, thus demonstrating the centrality of the PI3K/Akt pathway in lung fibroblast proliferation and differentiation. Moreover, for the first time we show that PI3K p110δ and p110γ are functionally expressed in human lung fibroblasts, in addition to the ubiquitously expressed p110α and β. Finally, results obtained with both selective inhibitors and gene knocking-down experiments demonstrate a major role of p110γ and p110α in both TGF-β-induced fibroblast proliferation and differentiation. This finding suggests that specific PI3K isoforms can be pharmacological targets in IPF.

Original languageEnglish
Article numbere24663
JournalPLoS One
Volume6
Issue number10
DOIs
Publication statusPublished - Oct 3 2011

Fingerprint

Myofibroblasts
phosphatidylinositol 3-kinase
Fibroblasts
Phosphatidylinositol 3-Kinases
Transforming Growth Factors
transforming growth factors
fibroblasts
Protein Isoforms
lungs
Lung
Idiopathic Pulmonary Fibrosis
fibrosis
Phosphatidylinositol 3-Kinase
Proto-Oncogene Proteins c-akt
Phosphorylation
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
Cell proliferation
Cell culture
Smooth Muscle
Muscle

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Inhibition of PI3K prevents the proliferation and differentiation of human lung fibroblasts into myofibroblasts : The role of class I P110 isoforms. / Conte, Enrico; Fruciano, Mary; Fagone, Evelina; Gili, Elisa; Caraci, Filippo; Iemmolo, Maria; Crimi, Nunzio; Vancheri, Carlo.

In: PLoS One, Vol. 6, No. 10, e24663, 03.10.2011.

Research output: Contribution to journalArticle

Conte, Enrico ; Fruciano, Mary ; Fagone, Evelina ; Gili, Elisa ; Caraci, Filippo ; Iemmolo, Maria ; Crimi, Nunzio ; Vancheri, Carlo. / Inhibition of PI3K prevents the proliferation and differentiation of human lung fibroblasts into myofibroblasts : The role of class I P110 isoforms. In: PLoS One. 2011 ; Vol. 6, No. 10.
@article{c7b47ccedc624f46b1f6f2eb1a8647d6,
title = "Inhibition of PI3K prevents the proliferation and differentiation of human lung fibroblasts into myofibroblasts: The role of class I P110 isoforms",
abstract = "Idiopathic pulmonary fibrosis (IPF) is a progressive fibroproliferative disease characterized by an accumulation of fibroblasts and myofibroblasts in the alveolar wall. Even though the pathogenesis of this fatal disorder remains unclear, transforming growth factor-β (TGF-β)-induced differentiation and proliferation of myofibroblasts is recognized as a primary event. The molecular pathways involved in TGF-β signalling are generally Smad-dependent yet Smad-independent pathways, including phosphatidylinositol-3-kinase/protein kinase B (PI3K/Akt), have been recently proposed. In this research we established ex-vivo cultures of human lung fibroblasts and we investigated the role of the PI3K/Akt pathway in two critical stages of the fibrotic process induced by TGF-β: fibroblast proliferation and differentiation into myofibroblasts. Here we show that the pan-inhibitor of PI3Ks LY294002 is able to abrogate the TGF-β-induced increase in cell proliferation, in α- smooth muscle actin expression and in collagen production besides inhibiting Akt phosphorylation, thus demonstrating the centrality of the PI3K/Akt pathway in lung fibroblast proliferation and differentiation. Moreover, for the first time we show that PI3K p110δ and p110γ are functionally expressed in human lung fibroblasts, in addition to the ubiquitously expressed p110α and β. Finally, results obtained with both selective inhibitors and gene knocking-down experiments demonstrate a major role of p110γ and p110α in both TGF-β-induced fibroblast proliferation and differentiation. This finding suggests that specific PI3K isoforms can be pharmacological targets in IPF.",
author = "Enrico Conte and Mary Fruciano and Evelina Fagone and Elisa Gili and Filippo Caraci and Maria Iemmolo and Nunzio Crimi and Carlo Vancheri",
year = "2011",
month = "10",
day = "3",
doi = "10.1371/journal.pone.0024663",
language = "English",
volume = "6",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "10",

}

TY - JOUR

T1 - Inhibition of PI3K prevents the proliferation and differentiation of human lung fibroblasts into myofibroblasts

T2 - The role of class I P110 isoforms

AU - Conte, Enrico

AU - Fruciano, Mary

AU - Fagone, Evelina

AU - Gili, Elisa

AU - Caraci, Filippo

AU - Iemmolo, Maria

AU - Crimi, Nunzio

AU - Vancheri, Carlo

PY - 2011/10/3

Y1 - 2011/10/3

N2 - Idiopathic pulmonary fibrosis (IPF) is a progressive fibroproliferative disease characterized by an accumulation of fibroblasts and myofibroblasts in the alveolar wall. Even though the pathogenesis of this fatal disorder remains unclear, transforming growth factor-β (TGF-β)-induced differentiation and proliferation of myofibroblasts is recognized as a primary event. The molecular pathways involved in TGF-β signalling are generally Smad-dependent yet Smad-independent pathways, including phosphatidylinositol-3-kinase/protein kinase B (PI3K/Akt), have been recently proposed. In this research we established ex-vivo cultures of human lung fibroblasts and we investigated the role of the PI3K/Akt pathway in two critical stages of the fibrotic process induced by TGF-β: fibroblast proliferation and differentiation into myofibroblasts. Here we show that the pan-inhibitor of PI3Ks LY294002 is able to abrogate the TGF-β-induced increase in cell proliferation, in α- smooth muscle actin expression and in collagen production besides inhibiting Akt phosphorylation, thus demonstrating the centrality of the PI3K/Akt pathway in lung fibroblast proliferation and differentiation. Moreover, for the first time we show that PI3K p110δ and p110γ are functionally expressed in human lung fibroblasts, in addition to the ubiquitously expressed p110α and β. Finally, results obtained with both selective inhibitors and gene knocking-down experiments demonstrate a major role of p110γ and p110α in both TGF-β-induced fibroblast proliferation and differentiation. This finding suggests that specific PI3K isoforms can be pharmacological targets in IPF.

AB - Idiopathic pulmonary fibrosis (IPF) is a progressive fibroproliferative disease characterized by an accumulation of fibroblasts and myofibroblasts in the alveolar wall. Even though the pathogenesis of this fatal disorder remains unclear, transforming growth factor-β (TGF-β)-induced differentiation and proliferation of myofibroblasts is recognized as a primary event. The molecular pathways involved in TGF-β signalling are generally Smad-dependent yet Smad-independent pathways, including phosphatidylinositol-3-kinase/protein kinase B (PI3K/Akt), have been recently proposed. In this research we established ex-vivo cultures of human lung fibroblasts and we investigated the role of the PI3K/Akt pathway in two critical stages of the fibrotic process induced by TGF-β: fibroblast proliferation and differentiation into myofibroblasts. Here we show that the pan-inhibitor of PI3Ks LY294002 is able to abrogate the TGF-β-induced increase in cell proliferation, in α- smooth muscle actin expression and in collagen production besides inhibiting Akt phosphorylation, thus demonstrating the centrality of the PI3K/Akt pathway in lung fibroblast proliferation and differentiation. Moreover, for the first time we show that PI3K p110δ and p110γ are functionally expressed in human lung fibroblasts, in addition to the ubiquitously expressed p110α and β. Finally, results obtained with both selective inhibitors and gene knocking-down experiments demonstrate a major role of p110γ and p110α in both TGF-β-induced fibroblast proliferation and differentiation. This finding suggests that specific PI3K isoforms can be pharmacological targets in IPF.

UR - http://www.scopus.com/inward/record.url?scp=80053452377&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053452377&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0024663

DO - 10.1371/journal.pone.0024663

M3 - Article

C2 - 21984893

AN - SCOPUS:80053452377

VL - 6

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 10

M1 - e24663

ER -